Is skin autofluorescence a novel non-invasive marker in diabetes? A systematic review and meta-analysis of case–control studies
Yasaman Sadeghi,MahboobehSadat Hosseini,Zahra Razavi,RazmanArabzadeh Bahri,AmirHoushang Ehsani,Alireza Firooz,Zeinab Aryanian,Ala Ehsani
DOI: https://doi.org/10.4103/jrms.jrms_127_23
2024-05-24
Journal of Research in Medical Sciences
Abstract:Diabetes mellitus (DM) is a major health issue globally. The incidence and prevalence of DM are increasing annually. DM as a serious, longstanding disorder displays a major influence on the quality of life and well-being of affected people, families, and societies all over the world. It is estimated to be one of the top 10 causes of death in adults. [ 1-3 ] Excess tissue glucose reacts with macromolecules such as nucleic acids, lipids, and proteins nonenzymatically, as a consequence, heterogeneous advanced glycation end products (AGE) would be produced. Thus, such irreversible alteration in macromolecule structures will impair their function. Although these reactions may occur under favorable conditions such as aging or smoking, serious oxidative stress disorders such as DM can accelerate tissue AGE accumulation. [ 4 ] Even in conditions of prepubertal diabetes, AGE was increased in association with hyperglycemia. [ 5 ] Specific AGE shows intrinsic fluorescence potency. Compared to plasma AGE, the measurement of skin autofluorescence (SAF) level by an AGE reader reflects tissue AGE more accurately. Accordingly, a strong relationship was found between SAF measurement and AGE accumulation by skin biopsy, glycated hemoglobin (HbA1c), or several diabetic complications. [ 6 ] Increased tissue AGE in body organs causes various pathologies that lead to organ dysfunction and complications. In our previous meta-analysis study, we obtained that higher SAF measurements were significantly associated with several diabetic complications, such as retinopathy, nephropathy, and neuropathy. [ 3 ] Similarly, a recent meta-analysis study demonstrated that SAF as a novel technology can successfully evaluate the risk of diabetic foot ulcers. [ 6 ] In addition, in a study, the authors suggested SAF measurement as a noninvasive technology for the detection of DM and individuals with impaired fasting glucose. [ 7 ] There are limited and discrete data comparing SAF levels in DM patients with nondiabetic individuals. Therefore, we aimed to design a systematic review and meta-analysis study of case-controls to validate tissue AGE measured by SAF in confirmed DM patients. This could be helpful to put a special concern on SAF level as a noninvasive, simple, and inexpensive method probably for earlier detection of DM cases or risk of DM complications and prevent them as possible.
medicine, general & internal